ArticleAnalytical and bioanalytical chemistry2025
Quantification of parathyroid hormone in high-purity materials by two isotope dilution mass spectrometry methods.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The development and use of isotope dilution mass spectrometry methods for the quantification of target proteins in certified reference materials.Analytical and bioanalytical chemistry · 2026Review
- Parathyroid hormone assay standardization in CKD-MBD: resolving heterogeneity for precision medicine.Frontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In clinical practice, the measurement of parathyroid hormone (PTH) typically employs immunoassays, but these methods lack comparability of results due to variations in specificity or calibration. Consequently, there is a clear need to establish a highly accurate and comparable procedure for a PTH calibrator. Purity assessment for a high-purity material is a prerequisite for the standardization of PTH assay. The present study proposes an accurate quantitative method for PTH purity in high-purity materials, integrating amino acid (AA) and peptide analysis for quantitative purposes. In the beginning, a liquid chromatography mass spectrometry (LC-MS) analysis was performed to confirm its molecular weight and AA sequence. Subsequently, three quantitative AAs were selected for accurate quantification of PTH by amino acid isotope dilution mass spectrometry (AA-IDMS). Finally, in peptide-IDMS, peptide ADVNVLTK (AK) was selected as the quantitative peptide to quantify PTH. The results of the two IDMS quantification methods exhibited strong concordance, with both exhibiting minimal uncertainty. The final mass fraction of PTH in the study material was calculated to be 0.718 ± 0.022 g/g. The method developed in this study provides novel technical support and theoretical foundations for the quality assessment and quality standard formulation of PTH-related products. It has great application potential in the purity determination of other bioactive substances with similar properties as PTH, and would promote the development of the field of bioanalysis.
Indexed as
Identifiers
40673916What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.